Muva nje, uShenzhen Jymed Technology Co, Ltd. (Laqishefeze Kubhekiselwe ku "Jeymed") uqede ngempumelelo amafayela wezidakamizwa amafayela (DMF) emikhiqizo emihlanu eyengeziwe nge-US Food and Drug Administration (FDA), ephindelela iphothifoliyo yayo yomkhiqizo.

Mayelana noJymed

I-Jmed iyinkampani ephezulu ye-biopharmaceutical egxile ocwaningweni oluzimele, ukuthuthukiswa, ukukhiqizwa kanye nokuthengiswa kwemikhiqizo esekwe kumaPereptide, kanye nentuthuko yenkontileka kanye nezinsizakalo zokukhiqiza (CDMO). Le nkampani izibophezele ekuhlinzekeni i-API esezingeni eliphakeme le-peptide kanye nezixazululo ezenziwe ngezifiso kumakhasimende omhlaba. Iphothifoliyo yomkhiqizo wayo ifaka inqwaba yama-apis ama-peptide, ngemikhiqizo eyisisekelo efana neSemaglutide ne-terligressin esevele isiqede ukugcwaliswa kwe-FDA DMF.

Uxhaso lwalo lokuxhaswa, lwe-Hubei JXbio Pharmaceutical Co, Ltd., Isebenzisa imigqa yokukhiqiza ye-Peptide-ye-Peptide-of-art peptide ehambisana namazinga we-CGMP ahambisana ne-US FDA, e-European Ema, ne-China's NMPA. Lesi sikhungo sifaka imigqa eyi-10 yokukhiqiza ephezulu kanye ne-Pilot futhi sisungule uhlelo lokuphathwa kwekhwalithi yesikhathi esiqinile (QMS) kanye nohlelo lokuphathwa kwezeMpilo yezeMvelo nezokuphepha (EHS). Lokhu kuqinisekisa ukuthi inqubo yonke, kusuka ku-R & D ukukhiqizwa, ihlangabezana namazinga aphakeme kakhulu. Le nkampani idlulise ngempumelelo ekuhlolweni kokutholwa kwe-GMP yi-US FDA ne-China's NMPA futhi yaqashelwa yizinkampani ezenzakalelayo zomhlaba wonke ngokuzibophezela kwayo kokuphathwa okuhle, ukuphepha, kanye nomsebenzi wezemvelo.

Izindawo zebhizinisi eliyisisekelo

Imikhiqizo eyinhloko

Ngemininingwane engaphezulu ngemikhiqizo yethu, sicela uxhumane nathi.

I-Global API nemibuzo yezimonyo: Ucingo No: + 86-5013529272;

Ukubhalisa kwe-API nezinsizakalo ze-CDMO (Imakethe ye-USA EU): + 86-15818682250

I-imeyili:jymed@jymedtech.com

Ikheli: Phansi 8 & 9, ukwakha 1, iShenzhen Biomedical Innovation Innovation Park, 14 Jinhui Road, Kengzi Subristrict, Pingzhen